August 6, 2008 - BioNanomatrix Inc., a developer of nanoscale whole genome imaging platforms for genetic diagnostics, personalized medicine and biomedical research, received a grant from the National Human Genome Research Institute of the U.S. National Institutes of Health (NIH) to develop a nanoscale platform for single-molecule haplotyping imaging.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now